Pictet Asset Management Holding Sa Tarsus Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 80,220 shares of TARS stock, worth $5.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,220
Previous 84,697
5.29%
Holding current value
$5.6 Million
Previous $4.35 Million
25.31%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
215Shares Held
46.5MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$228 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$217 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$208 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$172 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$171 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.86B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...